Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma exchange with human albumin in cirrhosis with acute-on-chronic liver failure
2010-021360-15Phase 4Completed
- Sponsor
- Instituto Grifols
- Start
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of albumin (human) in acute-on-chronic liver failure (ACLF), Cirrhosis and chronic liver disease (CLD), sponsored by Instituto Grifols. Primary endpoint: Functional capacity of serum albumin. Started Oct 2010; status: completed.
02
Drugs
albumin (human)
03
Conditions
acute-on-chronic liver failure (ACLF)Cirrhosischronic liver disease (CLD)
Beyond the preview
Go deeper on 2010-021360-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021360-15.